GeneID: 457


Common Name: miR-486-3p Type: Gene
Chromosome: 8 (NC_000008.11) Locus: NR_030161.1 (MIR486-1)
HUGO Symbol: MIR486-1 Full Name: microRNA 486-1
Exons: N/A Introns: N/A

MicroRNAs (miRNAs), such as MIR486-1, are small, non-coding RNAs that play key roles in the post-transcriptional regulation of gene expression by targeting specific mRNAs. MIR486-1 is highly conserved among mammals and is located on chromosome 8p11 within the Ankyrin-1 (ANK1) gene. It encodes two mature miRNAs, miR-486-3p and miR-486-5p. Alteration of both isoforms has been linked to cancers. In the haematopoietic system, both isoforms are strongly expressed in primary adult erythroid cells. Mounting evidence suggests that miR-486-3p plays a key role in the process of erythroid differentiation and foetal haemoglobin (HbF) regulation. miR-486-3p expression correlates with increased HbF synthesis in erythroid cells of beta-thalassaemia patients. miR-486-3p directly targets BCL11A [GeneID: 15], a known HbF repressor, by binding to the extra-long isoform of BCL11A 3′UTR, thereby affecting γ-globin gene expression. Therapeutic approaches that increase the HbF concentration have great potential for ameliorating the clinical and haematologic severity of beta-thalassaemia and other beta-haemoglobinopathies.

Synonyms: MIR486 , MIRN486 , mir-486-1 , hsa-mir-486 , hsa-mir-486-1


Number of entries/variants: 0

External Links


Publications / Origin

  1. Lulli V, Romania P, Morsilli O, Cianciulli P, Gabbianelli M, Testa U, Giuliani A, Marziali G, MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A., PLoS One, 8(4), e60436, 2013
  2. Lai K, Jia S, Yu S, Luo J, He Y, Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin., Oncotarget, 8(30), 49931-49943, 2017
  3. Eltaweel NH, ElKamah GY, Khairat R, Atia HAE, Amr KS, Epigenetic effects toward new insights as potential therapeutic target in B-thalassemia., J Genet Eng Biotechnol, 19(1), 51, 2021
Created on 2021-09-22 14:52:01, Last reviewed on (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.